Kane Biotech terminates old agreement with OTBC, enters new marketing agreement for $100,000

From GlobeNewswire: 2025-04-11 20:00:00

Kane Biotech Inc. has terminated a service agreement with OTBC and entered into a new agreement for marketing services. The company paid OTBC $100,000 for the previous agreement, but due to a change in TSX Venture Exchange policies, they had to terminate it. Under the new agreement, OTBC will be paid $100,000 in cash and receive an option to purchase 1,000,000 shares at an exercise price of $0.10 per share until April 11, 2026. Kane Biotech Inc. is a biotechnology company focused on preventing and removing microbial biofilms. For more information, visit their website.



Read more at GlobeNewswire: Kane Biotech Announces New Agreement with Outside the Box